NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MAAC | Montes Archimedes Acquisition Corp | Financial Services | Shell Companies | 2.31% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 2.27% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.25% |
| EHC | Encompass Health Corp | Healthcare | Medical Care Facilities | 2.22% |
| SWAV | Shockwave Medical Inc | Healthcare | Medical Devices | 2.22% |
| DVA | DaVita HealthCare Partners Inc | Healthcare | Medical Care Facilities | 2.19% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 2.17% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.16% |
| CI | Cigna Corp | Healthcare | Healthcare Plans | 2.15% |
| PINC | Premier Inc | Healthcare | Health Information Services | 2.1% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.08% |
| HCA | HCA Holdings Inc | Healthcare | Medical Care Facilities | 2.05% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 2.03% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 2.02% |
| DGX | Quest Diagnostics Incorporated | Healthcare | Diagnostics & Research | 1.84% |
| MOH | Molina Healthcare Inc | Healthcare | Healthcare Plans | 1.83% |
| ELV | Elevance Health Inc | Healthcare | Healthcare Plans | 1.81% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.8% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 1.79% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.75% |
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.